Similarly, miR-138 was significatively increased in MM-MSCs compared to HD-MSCs [42], and inhibition of miR-138 resulted in enhanced osteogenic differentiation of MM-MSCs, being ROCK2, TRPS1, and SULF2 potential miR-138 targets. This evidence concerns the gene TRPS1 and Miyoshi myopathy.